Chemoinformaics analysis of (7Z,10Z)-7,10-Hexadecadienal
| Molecular Weight | 236.399 | nRot | 12 |
| Heavy Atom Molecular Weight | 208.175 | nRig | 3 |
| Exact Molecular Weight | 236.214 | nRing | 0 |
| Solubility: LogS | -3.346 | nHRing | 0 |
| Solubility: LogP | 3.411 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 45 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 46.1922 |
| nHD | 0 | BPOL | 28.9578 |
| QED | 0.258 |
| Synth | 2.546 |
| Natural Product Likeliness | 1.541 |
| NR-PPAR-gamma | 0.777 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0 |
| HIA | 0.018 |
| CACO-2 | -4.838 |
| MDCK | 0.0000403 |
| BBB | 0.759 |
| PPB | 0.880386 |
| VDSS | 3.67 |
| FU | 0.032472 |
| CYP1A2-inh | 0.459 |
| CYP1A2-sub | 0.655 |
| CYP2c19-inh | 0.444 |
| CYP2c19-sub | 0.16 |
| CYP2c9-inh | 0.311 |
| CYP2c9-sub | 0.932 |
| CYP2d6-inh | 0.515 |
| CYP2d6-sub | 0.909 |
| CYP3a4-inh | 0.509 |
| CYP3a4-sub | 0.12 |
| CL | 5.006 |
| T12 | 0.887 |
| hERG | 0.184 |
| Ames | 0.706 |
| ROA | 0.012 |
| SkinSen | 0.974 |
| Carcinogencity | 0.643 |
| EI | 0.985 |
| Respiratory | 0.933 |
| NR-Aromatase | 0.232 |
| Antiviral | Yes |
| Prediction | 0.772702 |